Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Effect of Fluvastatin on Cardiovascular Complications in Kidney Transplant Patients: A Systemic Review and Meta-analysis.

Hwang SD, Lee JH, Jhee JH, Kim YJ, Park KM, Kim JK, Lee SW, Song JH.

Transplant Proc. 2019 Oct;51(8):2710-2713. doi: 10.1016/j.transproceed.2019.04.087. Epub 2019 Aug 22.

PMID:
31447193
2.

Belatacept for kidney transplant recipients.

Masson P, Henderson L, Chapman JR, Craig JC, Webster AC.

Cochrane Database Syst Rev. 2014 Nov 24;(11):CD010699. doi: 10.1002/14651858.CD010699.pub2. Review.

3.

HMG CoA reductase inhibitors (statins) for kidney transplant recipients.

Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2014 Jan 28;(1):CD005019. doi: 10.1002/14651858.CD005019.pub4. Review.

PMID:
24470059
4.

Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial.

Fellström B, Holdaas H, Jardine AG, Holme I, Nyberg G, Fauchald P, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Hartmann A, Logan JO, Pedersen TR; Assessment of Lescol in Renal Transplantation Study Investigators.

Kidney Int. 2004 Oct;66(4):1549-55.

5.

Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.

Webster AC, Wu S, Tallapragada K, Park MY, Chapman JR, Carr SJ.

Cochrane Database Syst Rev. 2017 Jul 20;7:CD004756. doi: 10.1002/14651858.CD004756.pub4. Review.

6.

Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.

Lo C, Jun M, Badve SV, Pilmore H, White SL, Hawley C, Cass A, Perkovic V, Zoungas S.

Cochrane Database Syst Rev. 2017 Feb 27;2:CD009966. doi: 10.1002/14651858.CD009966.pub2. Review.

7.

Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients.

Penninga L, Wettergren A, Wilson CH, Chan AW, Steinbrüchel DA, Gluud C.

Cochrane Database Syst Rev. 2014 Jun 5;(6):CD010253. doi: 10.1002/14651858.CD010253.pub2. Review.

PMID:
24901467
8.

Immunosuppressive T-cell antibody induction for heart transplant recipients.

Penninga L, Møller CH, Gustafsson F, Gluud C, Steinbrüchel DA.

Cochrane Database Syst Rev. 2013 Dec 2;(12):CD008842. doi: 10.1002/14651858.CD008842.pub2. Review.

PMID:
24297433
9.

Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients.

Webster A, Woodroffe RC, Taylor RS, Chapman JR, Craig JC.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003961. Review.

PMID:
16235347
10.

Extended release versus immediate release tacrolimus in kidney transplant recipients: a systematic review and meta-analysis.

Saengram W, Vadcharavivad S, Poolsup N, Chancharoenthana W.

Eur J Clin Pharmacol. 2018 Oct;74(10):1249-1260. doi: 10.1007/s00228-018-2512-7. Epub 2018 Jun 30. Review.

PMID:
29961086
11.

Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].

LeBlanc EL, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep.

12.

No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.

Fellström B, Abedini S, Holdaas H, Jardine AG, Staffler B, Gimpelewicz C; Assessment of Lescol in Renal Transplantation (ALERT) study group.

Clin Transplant. 2006 Nov-Dec;20(6):732-9.

PMID:
17100723
13.

Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study.

Norby GE, Holme I, Fellström B, Jardine A, Cole E, Abedini S, Holdaas H; Assessment of Lescol in Renal Transplantation Study Group.

Arthritis Rheum. 2009 Apr;60(4):1060-4. doi: 10.1002/art.24379.

14.

Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients.

Karpe KM, Talaulikar GS, Walters GD.

Cochrane Database Syst Rev. 2017 Jul 21;7:CD006750. doi: 10.1002/14651858.CD006750.pub2. Review.

15.

Antibody induction therapy for lung transplant recipients.

Penninga L, Møller CH, Penninga EI, Iversen M, Gluud C, Steinbrüchel DA.

Cochrane Database Syst Rev. 2013 Nov 27;(11):CD008927. doi: 10.1002/14651858.CD008927.pub2. Review.

16.

Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.

Knijnenburg SL, Mulder RL, Schouten-Van Meeteren AY, Bökenkamp A, Blufpand H, van Dulmen-den Broeder E, Veening MA, Kremer LC, Jaspers MW.

Cochrane Database Syst Rev. 2013 Oct 8;(10):CD008944. doi: 10.1002/14651858.CD008944.pub2. Review. Update in: Cochrane Database Syst Rev. 2019 Mar 11;3:CD008944.

PMID:
24101439
17.

Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.

Woodroffe R, Yao GL, Meads C, Bayliss S, Ready A, Raftery J, Taylor RS.

Health Technol Assess. 2005 May;9(21):1-179, iii-iv. Review.

18.

Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia.

Izquierdo-Palomares JM, Fernandez-Tabera JM, Plana MN, Añino Alba A, Gómez Álvarez P, Fernandez-Esteban I, Saiz LC, Martin-Carrillo P, Pinar López Ó.

Cochrane Database Syst Rev. 2016 Nov 26;11:CD009462. Review.

19.

Antihypertensive treatment for kidney transplant recipients.

Cross NB, Webster AC, Masson P, O'Connell PJ, Craig JC.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD003598. doi: 10.1002/14651858.CD003598.pub2. Review.

PMID:
19588343
20.

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.

Holdaas H, Fellström B, Jardine AG, Holme I, Nyberg G, Fauchald P, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Hartmann A, Solbu DO, Pedersen TR; Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators.

Lancet. 2003 Jun 14;361(9374):2024-31.

PMID:
12814712

Supplemental Content

Support Center